GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (WBO:ABT) » Definitions » Cyclically Adjusted PS Ratio

Abbott Laboratories (WBO:ABT) Cyclically Adjusted PS Ratio : 4.75 (As of May. 20, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Abbott Laboratories Cyclically Adjusted PS Ratio?

As of today (2024-05-20), Abbott Laboratories's current share price is €95.88. Abbott Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €20.20. Abbott Laboratories's Cyclically Adjusted PS Ratio for today is 4.75.

The historical rank and industry rank for Abbott Laboratories's Cyclically Adjusted PS Ratio or its related term are showing as below:

WBO:ABT' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.9   Med: 4.11   Max: 8.42
Current: 4.75

During the past years, Abbott Laboratories's highest Cyclically Adjusted PS Ratio was 8.42. The lowest was 1.90. And the median was 4.11.

WBO:ABT's Cyclically Adjusted PS Ratio is ranked worse than
68.5% of 473 companies
in the Medical Devices & Instruments industry
Industry Median: 2.18 vs WBO:ABT: 4.75

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Abbott Laboratories's adjusted revenue per share data for the three months ended in Mar. 2024 was €5.239. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €20.20 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Abbott Laboratories Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Abbott Laboratories's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Cyclically Adjusted PS Ratio Chart

Abbott Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.23 6.80 7.82 5.46 5.15

Abbott Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.92 5.21 4.55 5.15 5.19

Competitive Comparison of Abbott Laboratories's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Abbott Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Cyclically Adjusted PS Ratio falls into.



Abbott Laboratories Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Abbott Laboratories's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=95.88/20.2
=4.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Abbott Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.239/131.7762*131.7762
=5.239

Current CPI (Mar. 2024) = 131.7762.

Abbott Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 2.453 100.560 3.214
201409 2.593 100.428 3.402
201412 2.854 99.070 3.796
201503 2.986 99.621 3.950
201506 3.062 100.684 4.008
201509 3.049 100.392 4.002
201512 3.182 99.792 4.202
201603 2.957 100.470 3.878
201606 3.206 101.688 4.155
201609 3.200 101.861 4.140
201612 3.407 101.863 4.408
201703 3.414 102.862 4.374
201706 3.378 103.349 4.307
201709 3.266 104.136 4.133
201712 3.649 104.011 4.623
201803 3.395 105.290 4.249
201806 3.758 106.317 4.658
201809 3.703 106.507 4.582
201812 3.848 105.998 4.784
201903 3.754 107.251 4.612
201906 3.964 108.070 4.834
201909 4.110 108.329 5.000
201912 4.200 108.420 5.105
202003 3.927 108.902 4.752
202006 3.645 108.767 4.416
202009 4.204 109.815 5.045
202012 4.913 109.897 5.891
202103 4.903 111.754 5.781
202106 4.732 114.631 5.440
202109 5.192 115.734 5.912
202112 5.695 117.630 6.380
202203 6.086 121.301 6.612
202206 6.032 125.017 6.358
202209 5.962 125.227 6.274
202212 5.436 125.222 5.721
202303 5.197 127.348 5.378
202306 5.262 128.729 5.387
202309 5.436 129.860 5.516
202312 5.379 129.419 5.477
202403 5.239 131.776 5.239

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Abbott Laboratories  (WBO:ABT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Abbott Laboratories Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (WBO:ABT) Business Description

Address
100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Abbott Laboratories (WBO:ABT) Headlines

From GuruFocus

Q1 2020 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2023 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2020 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2021 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2021 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2020 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024